Brief: Adial Announces Positive Pre-Clinical Data For Purnovate's PNV-5030

Adial Pharmaceuticals

21/10/2021 15:35

Oct 21 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL ANNOUNCES POSITIVE PRE-CLINICAL DATA FOR PURNOVATE’S
PNV-5030 AS DRUG CANDIDATE FOR THE TREATMENT OF PAIN
    * ADIAL PHARMACEUTICALS INC - CLINICAL TRIAL EXPECTED TO
COMMENCE
IN 2022

Source text for Eikon:  ID:nGNX7Fjms3 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))